Augmedix, Inc. Quarterly Revenues in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Augmedix, Inc. quarterly/annual Revenues history and growth rate from Q1 2020 to Q3 2023.
  • Augmedix, Inc. Revenues for the quarter ending September 30, 2023 was $11.8M, a 49.6% increase year-over-year.
  • Augmedix, Inc. Revenues for the twelve months ending September 30, 2023 was $40.9M, a 42.3% increase year-over-year.
  • Augmedix, Inc. annual Revenues for 2022 was $30.9M, a 39.6% increase from 2021.
  • Augmedix, Inc. annual Revenues for 2021 was $22.2M, a 34.5% increase from 2020.
  • Augmedix, Inc. annual Revenues for 2020 was $16.5M, a 16.8% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $40.9M $11.8M +$3.9M +49.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $37M $10.8M +$3.45M +47% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $33.6M $9.63M +$2.64M +37.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $30.9M $8.75M +$2.17M +33.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $28.8M $7.86M +$2.24M +39.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $26.5M $7.33M +$2.16M +41.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $24.4M $6.99M +$2.2M +45.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $22.2M $6.58M +$2.03M +44.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $20.1M $5.63M +$1.38M +32.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 $18.8M $5.17M +$1.45M +38.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $17.3M $4.79M +$820K +20.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $16.5M $4.54M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $4.25M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.73M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.97M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.